Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GraniteShares 2x Long NVDA Daily ETF (NVDL) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance

GraniteShares 2x Long NVDA Daily ETFTrade
Oruka Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

GraniteShares 2x Long NVDA Daily ETF vs Oruka Therapeutics Inc. Common Stock — how do they compare? GraniteShares 2x Long NVDA Daily ETF trades at $33.1 (market cap $3.52B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Oruka Therapeutics Inc. Common Stock is the larger of the two by market cap, and Oruka Therapeutics Inc. Common Stock is more actively traded (490,798 versus 6,205,788). Which is the better fit depends on your goals — on Pluang, investors hold GraniteShares 2x Long NVDA Daily ETF for 15 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.

NVDLORKA
Market Cap
$3.52B$5.18B
Volume
6,205,788490,798
Sector
Leveraged / InverseHealth
52-Week High
$43.02$113.08
52-Week Low
$21.76$26.19
Typical Hold Time
15 Days0 Days
Enterprise Value
—$4.31B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GraniteShares 2x Long NVDA Daily ETF

NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $36.58 with a 1.81% daily gain. Technical indicators show a bullish overall signal with mixed moving averages and neutral oscillators. The ETF tracks Nvidia's performance with 2x daily leverage, though recent articles highlight it underperformed NVDA's 22.21% one-year return with only 17.21%. Recent news focuses on Nvidia's strong earnings and AI leadership driving optimism.

The outlook remains tied to Nvidia's AI dominance and earnings momentum, offering leveraged exposure to chip sector growth. Key risks include leverage decay, tracking error, and Nvidia's high valuation sensitivity. Investors should weigh the ETF's daily reset mechanism against long-term holding costs amid volatile tech markets.

Oruka Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NVDL
68% Buy32% Sell
Avg holding period · 15 Days
ORKA
100% Buy0% Sell
Avg holding period · 0 Days

About GraniteShares 2x Long NVDA Daily ETF

NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.

Read more on NVDL →

About Oruka Therapeutics Inc. Common Stock

Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.

Read more on ORKA →